Cisplatin-induced hair cell death requires STAT1 and is attenuated by epigallocatechin gallate

Journal of Neuroscience

Volumn 29, Issue 12, 2009, Pages 3843-3851

  Schmitt, Nicole C ^a,b   Rubel, Edwin W ^a,b   Nathanson, Neil M ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; EPIGALLOCATECHIN GALLATE; GAMMA INTERFERON; SERINE; STAT1 PROTEIN; ANTINEOPLASTIC AGENT; CATECHIN; DRUG DERIVATIVE; STAT1 PROTEIN, MOUSE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL DENSITY; CELL LOSS; CELL PROTECTION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EXPOSURE; DRUG MECHANISM; HAIR CELL; MOUSE; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; UTRICLE; ANIMAL; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; MOUSE MUTANT; PHOSPHORYLATION; PHYSIOLOGY; TISSUE CULTURE TECHNIQUE; VESTIBULE;

ANIMALS; ANTINEOPLASTIC AGENTS; CATECHIN; CELL DEATH; CISPLATIN; HAIR CELLS, AUDITORY; INTERFERON-GAMMA; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; SACCULE AND UTRICLE; SERINE; STAT1 TRANSCRIPTION FACTOR; TISSUE CULTURE TECHNIQUES;

EID: 64849117650     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5842-08.2009     Document Type: Article

References (51)

1. Barton C, Davies D, Balkwill F, Burke F (2005) Involvement of both intrinsic and extrinsic pathways in IFN-7gamma;-induced apoptosis that are enhanced with cisplatin. Eur J Cancer 41:1474-1486
2. Battle TE, Frank DA (2002) The role of STATs in apoptosis. CurrMol Med 2:381-392
3. Bodmer D, Brors D, Bodmer M, Pak K, Ryan AF (2003) Fas ligand expression in the organ of Corti. Audiol Neurootol 8:243-249
4. Chen D, Milacic V, Chen MS, Wan SB, Lam WH, Huo C, Landis-Piwowar KR, Cui QC, Wali A, Chan TH, Dou QP (2008) Tea polyphenols, their biological effects and potential molecular targets. Histol Histopathol 23:487-496.
5. ChiuLL, Cunningham LL, Raible DW, Rubel EW, Ou HC (2008) Using the zebrafish lateral line to screen for ototoxicity. J Assoc Res Otolaryngol 9:178-190.
6. Claudinon J, Monier M-N, Lamaze C (2007) Interfering with interferon receptor sorting and trafficking: impact on signaling. Biochimie 89:735-743.
7. Clerici WJ, Hensley K, DiMartino DL, Butterfield DA (1996) Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants. Hear Res 98:116-124.
8. Cunningham LL (2006) The adult mouse utricle as an in vitro preparation for studies of ototoxic-drug-induced sensory hair cell death. Brain Res 1091:277-281.
9. Cunningham LL, Brandon CS (2006) Heat shock inhibits both aminoglycosideand cisplatin-induced sensory hair cell death. J Assoc Res Otolaryngol 7:299-307.
10. Cunningham LL, Cheng AG, Rubel EW (2002) Caspase activation in hair cells of the mouse utricle exposed to neomycin. JNeurosci 22:8532-8540.
11. de Prati AC, Ciampa AR, Cavalieri E, Zaffini R, Darra E, Menegazzi M, Suzuki H, Mariotto S (2005) STAT1 as a new molecular target of antiinflammatory treatment. Curr Med Chem 12:1819-1828.
12. Devarajan P, Savoca M, Castaneda MP, Park MS, Esteban-Cruciani N, Kalinec G, Kalinec F (2002) Cisplatin-induced apoptosis in auditory hair cells: roll of death receptor and mitochondrial pathways. Hear Res 174:45-54.
13. DeVries TA, Kalkofen RL, Matassa AA, Reyland ME (2004) Protein kinase Cδ regulates apoptosis via activation of STAT1. J Biol Chem 279:45603-45612.
14. Haq R, Halupa A, Beattie BK, Mason JM, Zanke BW, Barber DL (2002) Regulation of erythropoietin-induced STAT serine phosphorylation by distinct mitogen-activated protein kinases. J Biol Chem 277:17359-17366.
15. Hsu SD, Singh BB, Lewis JB, Borke JL, Dickinson DP, Drake L, Caughman GB, Schuster GS (2002) Chemoprevention of oral cancer by green tea. Gen Dent 50:140-146.
16. Kim CH, Rang SU, Pyun J, Lee MH, Hwang HS, Lee H (2008) Epicatechin protects auditory cells against cisplatin-induced death. Apoptosis 13:1184-1194.
17. Kim HS, Lee M-S (2007) STAT1 as a key modulator of cell death. Cell Signal 19:454-465.
18. Klampfer L (2006) Signal transducers and activators of transcription (STATs): novel targets of chemopreventive and chemotherapeutic drugs. Curr Cancer Drug Targets 6:107-121.
19. Kovarik P, Stoiber D, Eyers PA, Menghini R, Neininger A, Gaestel M, Cohen P, Decker T (1999) Stress-induced phosphorylation of STAT1 at Ser727 requires p38 mitogen-activated protein kinase whereas IFN-7gamma; uses a different signaling pathway. Proc Natl Acad Sci U S A 96:13956-13961.
20. Lee HJ, Oh YK, Rhee M, Lim JY, Hwang JY, Park YS, Kwon Y, Choi KH, Jo I, Park SI, Gao B, Kim WH (2007) The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN. J Mol Biol 369:967-984.
21. Liu W, Staecker H, Stupak H, Malgrange B, Lefebvre P, Van de Water TR (1998) Caspase inhibitors prevent cisplatin-induced apoptosis of auditory sensory cells. Neuroreport 9:2609-2614.
22. Menegazzi M, Tedeschi E, Dussin D, De Prati AC, Cavalieri E, Mariotto S, Suzuki H (2001) Anti-interferon-γ action of epigallocatechin-3-gallate mediated by specific inhibition of STAT1 activation. FASEB J 15:1309-1311.
23. Meraz MA, White JM, Sheehan KG, Bach EA, Rodig ST, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguet M, Schreiber RD (1996) Targeted disruption of the Statl gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84:431-442.
24. Moriwaki K, Kiyomoto H, Hitomi H, Ihara G, Kaifu K, Matsubara K, Hara T, Kondo N, Ohmori K, Nishiyama A, Fukui T, Kohno M (2006) Interferon-γ enhances superoxide production in human mesangial cells via the JAK-STAT pathway. Kidney Int 70:788-793.
25. Oesterle EC, Campbell S, Taylor RR, Forge A, Hume CR (2008) Sox2 and JAGGED1 expression in normal and drug-damaged adult mouse inner ear. J Assoc Res Otolaryngol 9:65-89.
26. Previati M, Lanzoni I, Astolfi L, Fagioli F, Vecchiati G, Pagnoni A, Martini A, Capitani S (2007) Cisplatin cytotoxicity in organ of corti-derived immortalized cells. J Cell Biochem 101:1185-1197.
27. Ramesh G, Reeves WB (2002) TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 110:835-842.
28. Reser D, Rho M, Dewan D, Herbst L, Li G, Stupak H, Zur K, Romaine J, Frenz D, Goldbloom L, Kopke R, Arezzo J, Van De Water T (1999) land D-methionine provide equivalent long term protection against CDDPinduced ototoxicity in vivo, with partial in vitro and in vivo retention of antineoplastic activity. Neurotoxicology 20:731-748.
29. Rybak LP, Kelly T (2003) Ototoxicity: bioprotective mechanisms. Curr Opin Otolaryngol Head Neck Surg 11:328-333.
30. Rybak LP, Whitworth CA, Mukherjea D, Ramkumar V (2007) Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res 226:157-167.
31. Schuldes H, Bade S, Knobloch J, Jonas D (1997) Loss of in vitro cytotoxicity after storage of stock solution in cell culture medium at various temperatures. Cancer 79:1723-1728.
32. Simon AR, Rai U, Fanburg BL, Cochran BH (1998) Activation of the JAKSTAT pathway by reactive oxygen species. Am J Physiol Cell Physiol 275:1640-1652.
33. So H, Kim H, Lee JH, Park C, Kim Y, Kim E, Kim JK, Yun KJ, Lee KM, Lee HY, Moon SK, Lim DJ, Park R (2007) Cisplatin cytotoxicity of auditory cells requires secretions of proinflammatory cytokines via activation of ERK and NF-kappaB. J Assoc Res Otolaryngol 8:338-355.
34. Stempelj M, Kedinger M, Augenlicht L, Klampfer L (2007) Essential role of the JAK/STAT1 signaling pathway in the expression of inducible nitricoxide synthase in intestinal epithelial cells and its regulation by butyrate. J Biol Chem 282:9797-9804.
35. Stephanou A, Scarabelli TM, Brar BK, Nakanishi Y, Matsumura M, Knight RA, Latchman DS (2001) Induction of apoptosis and Fas receptor/Fas ligand expression by ischemia/reperfusion in cardiac myocytes requires serine 727 of the STAT-1 transcription factor but not tyrosine 701. J Biol Chem 276:28340-28347.
36. Stephanou A, Scarabelli TM, Townsend PA, Bell R, Yellon D, Knight RA, Lachtman DS (2002) The carboxyl-terminal activation domain of the STAT-1 transcription factor enhances ischemia/reperfusion-induced apoptosis in cardiac myocytes. FASEB J 13:1841-1843.
37. Takagi Y, Harada J, Chiarugi A, Moskowitz MA (2002) STAT1 is activated in neurons after ischemia and contributes to ischemic brain injury. J Cereb Blood Flow Metab 22:1311-1318.
38. Tedeschi E, Suzuki H, Menegazzi M (2002) Antiinflammatory action of EGCG, the main component of green tea, through STAT-1 inhibition. Ann N Y Acad Sci 973:435-437.
39. Terui K, Haga S, Enosawa S, Ohnuma N, Ozaki M (2004) Hypoxia/ reoxygenation-induced, redox-dependent activation of Statl confers resistance to apoptotic cell death via hsp70 induction. Biochem J 380:203-209.
40. Townsend PA, Scarabelli TM, Davidson SM, Knight RA, Latchman DS, Stephanou A (2004a) STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis. J Biol Chem 279:5811-5820.
41. Townsend PA, Scarabelli TM, Pasini E, Gitti G, Menegazzi M, Suzuki H, Knight RA, Lachtman DS, Stephanou A (2004b) Epigallocatechin-3gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/reperfusion- induced apoptosis. FASEB J 8:1621-1623.
42. Wang J, Ladrech S, Pujol R, Brabet P, Van de Water T, Puel J-L (2004) Caspase inhibitors, but not c-Jun. NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss. Cancer Res 64:9217-9224.
43. Wozniak K, Blasiak J (2002) Recognition and repair of DNA-cisplatin adducts. Acta Biochim Pol 49:583-596.
44. Xiao L, Naganawa T, Obugunde E, Gronowicz G, Ornitz DM, Coffin JD, Hurley MH (2004) Statl controls postnatal bone formation by regulating fibroblast growth factor signaling in osteoblasts. J Biol Chem 279:27743-27752.
45. 2O2-induced oxidizing damage. Acta Otolaryngol 124:464-470.
46. Yamamoto T, Staples J, Wataha J, Lewis J, Lockwood P, Schoenlein P, Rao S, Osaki T, Dickinson D, Kamatani T, Schuster G, Hsu S (2004) Protective effects of EGCG on salivary gland cells treated with 7gamma;-radiation or cisplatinum (II) diammine dichloride. Anticancer Res 24:3065-3074.
47. Yamashita H, Oesterle EC (1995) Induction of cell proliferation in mammalian inner ear sensory epithelia by transforming growth factor-alpha and epidermal growth factor. Proc Natl Acad Sci U S A 92:3152-3155.
48. Yan HY. SaidelWM, Chang JS, Presson JC, Popper AN (1991) Sensory hair cells of a fish ear: evidence of multiple types based on ototoxicity sensitivity. Proc R Soc Lond B Biol Sci 245:133-138.
49. Youlyouz-Marfak I, Gachard N, Le Clorennec C, Najjar I, Baran-Marszak F, Reminieras L, May E, Bornkamm GW, Fagard R, Feuillard J (2008) Identification of a novel p53-dependent activation pathway of'STATl by antitumour genotoxic agents. Cell Death Differ 15:376-385.
50. Zhang M, Liu W, Ding D, Salvi R (2003) Pifithrin-α suppresses p53 and protects cochlear and vestibular hair cells from cisplatin-induced apoptosis. Neuroscience 120:191-205.
51. Zykova TA, ZhangY, Zhu F, Bode AM, Dong Z (2005) The signal transduction networks required for phosphorylation of STAT1 at Ser727 in mouse epidermal JB6 cells in the UVB response and inhibitory mechanisms of tea polyphenols. Carcinogenesis 26:331-342.